Genji Iwasaki

876 total citations
36 papers, 481 citations indexed

About

Genji Iwasaki is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Genji Iwasaki has authored 36 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Genji Iwasaki's work include Chemical Reaction Mechanisms (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Enzyme Catalysis and Immobilization (4 papers). Genji Iwasaki is often cited by papers focused on Chemical Reaction Mechanisms (6 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Enzyme Catalysis and Immobilization (4 papers). Genji Iwasaki collaborates with scholars based in Japan, Switzerland and United Kingdom. Genji Iwasaki's co-authors include Masatomo Hamana, Masakatsu Shibasaki, Seitaro Saeki, Takamasa Iimori, Kiyosi Kondô, Ichiro Mori, Yoko Kimura, Yutaka Suto, Daisaku Ohta and Noriyuki Yamagiwa and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and PLANT PHYSIOLOGY.

In The Last Decade

Genji Iwasaki

35 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genji Iwasaki Japan 14 279 210 45 44 32 36 481
Pierre Demerseman France 14 391 1.4× 149 0.7× 43 1.0× 26 0.6× 56 1.8× 62 520
John Scheigetz Canada 16 334 1.2× 258 1.2× 46 1.0× 59 1.3× 30 0.9× 35 593
Mark A. Zottola United States 11 210 0.8× 165 0.8× 28 0.6× 21 0.5× 16 0.5× 17 399
Catherine Fontaine France 16 164 0.6× 228 1.1× 74 1.6× 82 1.9× 28 0.9× 31 499
Keith C. Ellis United States 15 300 1.1× 309 1.5× 34 0.8× 69 1.6× 26 0.8× 28 682
David M. Hollinshead United Kingdom 13 320 1.1× 119 0.6× 26 0.6× 55 1.3× 34 1.1× 17 450
Miloslav Černý Czechia 14 397 1.4× 356 1.7× 26 0.6× 33 0.8× 71 2.2× 53 580
Théophile Tschamber France 15 479 1.7× 252 1.2× 71 1.6× 53 1.2× 28 0.9× 51 600
J. S. MENDOZA United States 16 496 1.8× 176 0.8× 21 0.5× 39 0.9× 24 0.8× 22 630
J. L. VAN DER BAAN Netherlands 15 398 1.4× 213 1.0× 51 1.1× 91 2.1× 30 0.9× 49 589

Countries citing papers authored by Genji Iwasaki

Since Specialization
Citations

This map shows the geographic impact of Genji Iwasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genji Iwasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genji Iwasaki more than expected).

Fields of papers citing papers by Genji Iwasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genji Iwasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genji Iwasaki. The network helps show where Genji Iwasaki may publish in the future.

Co-authorship network of co-authors of Genji Iwasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Genji Iwasaki. A scholar is included among the top collaborators of Genji Iwasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genji Iwasaki. Genji Iwasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chakraborty, J.N., Genji Iwasaki, & Yasuhisa Asano. (2025). The Development of Synthetic Routes Leading to Pharmaceuticals and the Key Intermediates Using Hydroxynitrile Lyase. The Journal of Organic Chemistry. 90(22). 7306–7317. 1 indexed citations
2.
Sato, Mariko, Hiromu Sugiyama, Yutaka Suto, et al.. (2023). GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c‐MET tyrosine kinase. Cancer Medicine. 12(8). 9749–9759. 3 indexed citations
3.
Suto, Yutaka, Mariko Sato, Daiju Ichikawa, et al.. (2017). Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma. Bioorganic & Medicinal Chemistry Letters. 27(19). 4558–4563. 8 indexed citations
4.
Suto, Yutaka, et al.. (2015). Synthesis and biological evaluation of quinones derived from natural product komaroviquinone as anti-Trypanosoma cruzi agents. Bioorganic & Medicinal Chemistry Letters. 25(15). 2967–2971. 17 indexed citations
5.
Ehara, Takeru, Fumiaki Yokokawa, Junichi Sakaki, et al.. (2008). Discovery of selective and nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 3959–3962. 14 indexed citations
6.
Teno, Naoki, et al.. (2008). New chemotypes for cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2599–2603. 12 indexed citations
7.
Yokokawa, Fumiaki, Takeru Ehara, Yuki Iwaki, et al.. (2008). 4-Amino-2-cyanopyrimidines: Novel scaffold for nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(16). 4642–4646. 10 indexed citations
8.
Sakaki, Junichi, Toshiki Murata, Thomas Pitterna, et al.. (1998). Discovery of IRL 3461: a novel and potent endothelin antagonist with balanced ETA/ETB affinity. Bioorganic & Medicinal Chemistry Letters. 8(16). 2241–2246. 7 indexed citations
9.
Mori, Ichiro, Yoko Kimura, Shin-ichiro Matsunaga, et al.. (1997). Trimethylsilyl triflate promoted 1,4-addition of silyl phosphites to cyclic enones. Tetrahedron Letters. 38(20). 3543–3546. 19 indexed citations
10.
Mori, Ichiro, Yoko Kimura, Genji Iwasaki, et al.. (1995). A Novel Class of Herbicides (Specific Inhibitors of Imidazoleglycerol Phosphate Dehydratase). PLANT PHYSIOLOGY. 107(3). 719–723. 53 indexed citations
11.
Kheirolomoom, Azadeh, et al.. (1994). Steady-State Kinetics of Cabbage Histidinol Dehydrogenase. Archives of Biochemistry and Biophysics. 312(2). 493–500. 15 indexed citations
12.
Iwasaki, Genji, et al.. (1993). Synthesis of (2R,3R)-, (2S,3S)-, (2R,3S)- and (2S,3R)-imidazole glycerol phosphates (IGP): substrates for IGP-dehydratase (IGPD). Bioorganic & Medicinal Chemistry Letters. 3(10). 2129–2134. 9 indexed citations
13.
Iwasaki, Genji, et al.. (1989). A practical and diastereoselective synthesis of angiotensin converting enzyme inhibitors.. Chemical and Pharmaceutical Bulletin. 37(2). 280–283. 41 indexed citations
14.
Iwasaki, Genji, et al.. (1988). Asymmetric synthesis of (2R)-2-hydroxy-2-(2(Z)-octenyl)-1-cyclopentanone. The Journal of Organic Chemistry. 53(20). 4864–4867. 8 indexed citations
15.
16.
Iwasaki, Genji, Seitaro Saeki, & Masatomo Hamana. (1986). NUCLEOPHILIC SUBSTITUTION OF p-DINITROBENZENE WITH SOME CARBANIONS. FORMATION OF p-SUBSTITUTED NITROBENZENES. Chemistry Letters. 15(1). 31–34. 7 indexed citations
17.
Iwasaki, Genji, et al.. (1985). ChemInform Abstract: FACILE FORMATION OF 2,2′‐DIQUINOLYLMETHANE N,N′‐DIOXIDES AND MONO‐N‐OXIDES AND RELATED REACTIONS. Chemischer Informationsdienst. 16(4). 1 indexed citations
18.
Hamana, Masatomo, Genji Iwasaki, Seitaro Saeki, & Kazuko Wada. (1985). Reactions of Quinoline N-Oxides and Nitrobenzenes with Methylquinoline and -Pyridine Derivatives in the Presence of t-BuOK. Heterocycles. 23(1). 175–175.
19.
Iwasaki, Genji, et al.. (1984). 2,2′-ジキノリルメタンN,N-ジオキシドとモノ-N-オキシドの容易な生成および関連反応. Heterocycles. 22(8). 1811–1815. 11 indexed citations
20.
Hamana, Masatomo, Genji Iwasaki, & Seitaro Saeki. (1982). Nucleophilic Substitution of 4-Chloroguinoline 1-Oxide and Related Compounds by Means of Hydride Elimination. Heterocycles. 17(1). 177–177. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026